MiMedx Group, Inc. is a leading regenerative medicine company headquartered in Marietta, Georgia, specializing in the development and distribution of placental tissue allografts. These innovative products are utilized across multiple healthcare sectors, including wound care and surgical applications, with a focus on enhancing healing processes. By leveraging its proprietary technology and extensive research, MiMedx aims to improve patient outcomes while addressing the needs of healthcare providers in a rapidly evolving medical landscape.
Click "Analyze" to generate stock analysis
MDXG Price Trend and Signals
MDXG Option Volumes & Open Interests (aggregated)
MDXG Put Call Ratios and IV (aggregated)
MDXG Financials
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-29Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.